IMMOMEDIC: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
IMMOMEDIC
Largest movements
- Tangible fixed assets -€37,965
down €37,965 (-6.0%), from €631,163 to €593,199
of which Land and buildings: -€32,375
- Debts after one year -€43,536
down €43,536 (-8.8%), from €495,598 to €452,062
- Gross operating margin -€7,586
down €7,586 (-11.3%), from €66,958 to €59,373
- Depreciation +€5,278
up €5,278 (+15.0%), from €35,302 to €40,581
- Financial charges -€851
down €851 (-7.1%), from €11,944 to €11,093
- Taxes -€778
down €778 (-37.1%), from €2,097 to €1,319
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €651,895 | €613,013 | -€38,882 | -6.0% |
| Fixed assets | 21/28 | €631,163 | €593,199 | -€37,965 | -6.0% |
| Tangible fixed assets | 22/27 | €631,163 | €593,199 | -€37,965 | -6.0% |
| Land and buildings | 22 | €604,475 | €572,100 | -€32,375 | -5.4% |
| Plant, machinery and equipment | 23 | €26,689 | €21,099 | -€5,590 | -20.9% |
| Current assets | 29/58 | €20,732 | €19,814 | -€918 | -4.4% |
| Amounts receivable within one year | 40/41 | - | €2,681 | +€2,681 | |
| Other amounts receivable | 41 | - | €2,681 | +€2,681 | |
| Cash at bank and in hand | 54/58 | €12,708 | €11,841 | -€867 | -6.8% |
| Deferred charges and accrued income | 490/1 | €8,024 | €5,292 | -€2,732 | -34.0% |
| Total equity and liabilities | 10/49 | €651,895 | €613,013 | -€38,882 | -6.0% |
| Equity | 10/15 | €49,636 | €53,719 | +€4,084 | +8.2% |
| Contributions | 10/11 | €6,300 | €6,300 | = | 0.0% |
| Reserves | 13 | €43,336 | €47,419 | +€4,084 | +9.4% |
| Distributable reserves | 133 | €43,336 | €47,419 | +€4,084 | +9.4% |
| Amounts payable | 17/49 | €602,260 | €559,294 | -€42,966 | -7.1% |
| Amounts payable after more than one year | 17 | €495,598 | €452,062 | -€43,536 | -8.8% |
| Financial debts | 170/4 | €495,598 | €452,062 | -€43,536 | -8.8% |
| Amounts payable within one year | 42/48 | €103,718 | €106,298 | +€2,579 | +2.5% |
| Current portion of amounts payable after more than one year | 42 | €45,942 | €46,878 | +€936 | +2.0% |
| Trade debts | 44 | €948 | €2,591 | +€1,643 | +173% |
| Suppliers | 440/4 | €948 | €2,591 | +€1,643 | +173% |
| Taxes, remuneration and social security | 45 | €97 | €97 | +€0 | 0.0% |
| Taxes | 450/3 | €97 | €97 | +€0 | 0.0% |
| Other amounts payable | 47/48 | €56,731 | €56,731 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €2,943 | €933 | -€2,010 | -68.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €35,302 | €40,581 | +€5,278 | +15.0% |
| Other operating charges | 640/8 | €1,952 | €2,296 | +€344 | +17.6% |
| Gross operating margin | 9900 | €66,958 | €59,373 | -€7,586 | -11.3% |
| Operating profit (loss) | 9901 | €29,705 | €16,496 | -€13,208 | -44.5% |
| Financial charges | 65/66B | €11,944 | €11,093 | -€851 | -7.1% |
| Recurring financial charges | 65 | €11,944 | €11,093 | -€851 | -7.1% |
| Profit (loss) for the period before taxes | 9903 | €17,760 | €5,403 | -€12,357 | -69.6% |
| Income taxes | 67/77 | €2,097 | €1,319 | -€778 | -37.1% |
| Profit (loss) for the period | 9904 | €15,663 | €4,084 | -€11,579 | -73.9% |
| Profit (loss) for the period to be appropriated | 9905 | €15,663 | €4,084 | -€11,579 | -73.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.